But I do think it needs to be shown to be safe, so at least the first phase of that. We were at some of the FDA public hearings that they had back in May, and I think that was issue number one. There are some unscrupulous actors in this space. These people, whoever they are, I mean, when they say it’s the Wild West, that’s what it sort of looks like, because they’re taking advantage of the absence of regulations to pump out cheaper, sometimes entirely synthetic, and sometimes dangerous products in the market.
Cannabis Wire co-founder and editor Nushin Rashidian caught up with Gupta to learn more about the latest documentary, and his thoughts on forthcoming FDA regulations that will determine the future of the so-called CBD craze.
“I don’t think it should just be pharma route,” Gupta said about the CBD regulations under consideration by the FDA, which will determine whether the compound can be in food and supplements, or only in pharmaceuticals.
(This interview has been edited for length and clarity.)
Since then, Gupta and CNN have produced several more documentaries in the series, for which Gupta has traveled the world to learn how cannabis research is unfolding in places like Israel, and what lessons could potentially be considered here in the US, where the federal government still does not classify cannabis as medicine while more than 30 states have. And on Sunday, the fifth installment will air, called WEED 5: The CBD Craze.
Gupta: For people following it over the last couple of years, it’s been a pretty abrupt turnaround, that’s what they feel like. They couldn’t say the word, they didn’t know what CBD was exactly around that time, 2013, 2014. And now, as you say, it’s available everywhere. I think there are some concerns with that, frankly. When we talked about Charlotte, when we were representing that work, it was always around the medicinal aspect of this: Why couldn’t this be studied like any other compound? What were the barriers to that?
Gupta: There’s plenty of supplements out there and the supplement market has been pretty unregulated. And I think that that’s been a concern aside from from CBD. When we think about regulation, I would say that there’s three phases to trialling these things from a pharma standpoint, which is: one, to prove that it’s safe, two, to prove that it’s effective, and three, to see how it compares to other existing therapies. I don’t know that I would necessarily say that CBD has to receive the same sort of approvals as pharma by any means. I think that’s not practical. It’s very expensive and that would certainly make it not available to people more widely.
Cannabis is a complex plant with more than 400 chemical compounds, but the two most prevalent cannabinoids are tetrahydrocannabinol, or THC, and cannabidiol, or CBD — and they’re the compounds responsible for raising cannabis’ profile in the medical community.
“It is important to check with your health professional, whether your CBD is derived from hemp or your CBD is derived from marijuana. While research on CBD is promising, it is still a compound with potentially wide effects in our body and can interact with the medications that you are taking . and can make their effects more powerful.” Chin said.
Hemp-derived CBD versus CBD derived from marijuana (cannabis)
Additionally, there is anecdotal data showing that CBD oil is useful for a variety of inflammatory skin diseases including eczema and psoriasis, Zeichner said. “The skin has a large amount of CBD receptors, so there is great potential. But we need to separate the beauty hype from the reality,” Frankel said.
In 2019, the Farm Bill made it legal to grow hemp in the United States and legal to sell hemp-derived CBD products grown in the US as well as abroad, as long as the hemp plants and hemp-derived products contain less than 0.3 percent of THC per dry weight. However, the bill does not cover CBD derived from marijuana, even if THC is removed.
“Health-care workers [who] are working long shifts are finding CBD helpful for restorative sleep and on their days off using it for pain and inflammation — from being on their feet all day, [and having] low back pain and neck pain,” Chin said in an email.
To begin with, overall, the efficacy of rich CBD dosed extracts to help treat seizures, particularly in treatment resistant seizure disorders, is well established. I have seen two children, under the age of 7 in the past two weeks alone, where their seizures, both having 3-4 grand mals per day, go to having less than one limited seizure per week. Can you imagine how this changes the life of the child as well as parents and other family members? It certainly always places a big smile on my face.
Cookie Bekkar is a cancer survivor and patient of Dr Frankel's. She has created a website to share her story, what worked well for her and as a resource help inspire/educate other patients.
With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.
The ratio of cannabinoids and dosing is clearly somewhat debated. I know that groups in Colorado are using a CBD dose of 1 mg per pound. I think this is pretty excessive for most kids and have spoken with one mother whose child was becoming sedated. Remember, although CBD may not be psychoactive, the whole plant version of CBD with all the other cannabinoids and minor cannabinoids makes the medicine somewhat psychoactive – particularly in higher doses.
You Might Also Enjoy.